20 results match your criteria: "417 Army Share Fund Hospital (NIMTS)[Affiliation]"
Familial mediterranean fever in a patient with ankylosing spondylitis: could familial mediterranean fever explain a typical eight-year ankylosing spondylitis?
Rheumatol Int
December 2024
Department of Rheumatology, 417 Army Share Fund Hospital (NIMTS), 10-12 Monis Petraki Str, 11521, Athens, Greece.
Article Synopsis
- * A unique case is presented where a patient with a long history of AS was diagnosed with FMF after experiencing recurrent symptoms; laboratory tests confirmed the condition.
- * The patient's treatment with colchicine led to significant improvement, emphasizing the importance of recognizing the relationship between AS and FMF in medical practice.
Optimal management of ocular complications in axial spondyloarthritis: rethinking subcutaneous infliximab.
Rheumatology (Oxford)
August 2024
Department of Rheumatology, 417 Army Share Fund Hospital (NIMTS), Athens, Greece.
Assessment of extra-coronary peripheral arteriopathy in spontaneous coronary dissection: state of the art in non-invasive imaging techniques and future perspectives.
Eur Heart J Imaging Methods Pract
September 2023
Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, National and Heart Lung Institute, Imperial College London, Sydney St, London SW3 6NP, UK.
Article Synopsis
- Spontaneous coronary artery dissection (SCAD) is a key cause of heart issues for women under 50, especially during pregnancy, connecting it to systemic arterial disorders like Ehlers-Danlos and Marfan syndromes.
- It often coexists with conditions like fibromuscular dysplasia and other vascular abnormalities, highlighting a genetic link to SCAD.
- The American Heart Association suggests using advanced imaging, like computed tomography angiography (CTA) and magnetic resonance angiography (MRA), for better diagnosis of related vascular disorders, focusing on the effectiveness of these non-invasive methods.
New-Onset MDA-5 Dermatomyositis in a Patient Following COVID-19 Vaccination: A Case Report.
Mediterr J Rheumatol
March 2024
Department of Rheumatology, 417 Army Share Fund Hospital (NIMTS), Athens, Greece.
Article Synopsis
- * There are concerns that COVID-19 vaccines might cause autoimmune diseases in previously healthy people, with a case reported of a patient developing anti-MDA5 positive dermatomyositis after receiving the third vaccine dose.
- * The patient experienced severe symptoms and required multiple treatments, including corticosteroids and rituximab, highlighting the need for further investigation on the rare autoimmune responses potentially linked to COVID-19 vaccines.
Guest Editors Bio.
Transfus Apher Sci
February 2024
Nephrology Department at Athens, 417 Army Share Fund Hospital (NIMTS), Greece. Electronic address:
Musculoskeletal Complications of Celiac Disease: A Case-Based Review.
Mediterr J Rheumatol
March 2023
First Department of Propaedeutic Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Article Synopsis
- * A case study of a 66-year-old man showed that his back and knee pain were linked to celiac disease, along with osteoporosis and vitamin D deficiency, discovered through thorough testing.
- * Following a gluten-free diet and supplements for vitamin D and calcium led to major improvements in his symptoms and bone mineral density after six months, highlighting the need for rheumatologists to recognize the musculoskeletal symptoms associated with CD.
Cranial giant cell arteritis mimickers: A masquerade to unveil.
Autoimmun Rev
May 2022
Rheumatology Unit, First Department of Propaedeutic Internal Medicine, School of Medicine, Laiko Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Giant cell arteritis (GCA) is a large-vessel vasculitis that affects cranial and extra-cranial arteries. Extra-cranial GCA presents mainly with non-specific symptoms and the differential diagnosis is very broad, while the cranial form has more typical clinical picture and physicians have a lower threshold for diagnosis and treatment. Although temporal artery biopsy (TAB) has an established role, ultrasound (US) is being increasingly used as the first-line imaging modality in suspected GCA.
View Article and Find Full Text PDFZoledronic acid is effective in the management of migratory osteoporosis unresponsive to conservative treatment and risedronate: A case report.
J Musculoskelet Neuronal Interact
March 2021
Rheumatology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece.
Article Synopsis
- A 55-year-old woman diagnosed with migratory osteoporosis (MO) experienced pain and bone marrow edema in her left ankle, initially treated with non-weight-bearing methods and risedronate.
- Despite some initial improvement, the condition worsened, affecting her foot and left hip, indicating that the initial treatment was ineffective.
- Ultimately, a single infusion of zoledronic acid led to complete pain relief and resolution of bone marrow edema, allowing her to return to daily activities, highlighting the need for more robust treatment for MO.
A Case of Microscopic Polyangiitis Presenting as Cranial Giant Cell Arteritis.
Mediterr J Rheumatol
December 2020
Rheumatology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece.
Article Synopsis
- - A 63-year-old man initially presented with symptoms resembling giant cell arteritis (GCA) but was later diagnosed with microscopic polyangiitis (MPA) after further evaluation.
- - His treatment began with corticosteroids for what was thought to be GCA, but after complications arose, tests revealed positive p-ANCA antibodies.
- - The patient underwent successful treatment with cyclophosphamide, achieving remission from MPA, and has remained symptom-free for two years.
Correspondence on 'Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia'.
Ann Rheum Dis
February 2023
Rheumatology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece.
Hypogammaglobulinemia after rituximab for rheumatoid arthritis is not rare and is related with good response: 13 years real-life experience.
Rheumatology (Oxford)
May 2021
Rheumatology Department, 417 Army Share Fund Hospital (NIMTS).
Article Synopsis
- Rituximab (RTX) treatment for rheumatoid arthritis (RA) can lead to hypogammaglobulinemia (HGG), a decrease in immunoglobulin levels (IgG, IgM, IgA), affecting patient outcomes and infection rates.
- In a study of 83 RA patients treated with RTX, nearly 43% experienced HGG, with lower baseline immunoglobulin levels predicting the occurrence of low IgG and low IgM.
- Interestingly, patients who developed low IgM showed better disease activity outcomes, while the development of HGG did not result in a higher rate of serious infections.*
Tuberculosis and targeted synthetic or biologic DMARDs, beyond tumor necrosis factor inhibitors.
Ther Adv Musculoskelet Dis
June 2020
Rheumatology Unit, First Department of Propaedeutic Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Article Synopsis
- - Patients with autoimmune rheumatic diseases (ARD) have a heightened risk of developing tuberculosis (TB), especially when treated with tumor necrosis factor inhibitors (TNFi) and glucocorticoids, which can lead to latent TB reactivation.
- - Recent biologic and targeted synthetic DMARDs (like rituximab and JAK inhibitors) seem to show a lower TB risk compared to TNFi, although more real-life data is needed for a clearer understanding.
- - It's crucial to screen for latent TB before starting any DMARD treatment, and further studies are necessary to compare TB risks among different ARD treatment options.
A Varicella Case After Herpes-Zoster Vaccination in a Patient Treated With a Tumor Necrosis Factor Inhibitor.
J Clin Rheumatol
October 2021
From the Rheumatology Department, 417 Army Share Fund Hospital (NIMTS).
Zoledronic acid in nine patients with transient osteoporosis of the hip.
Clin Rheumatol
January 2020
Rheumatology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece.
Temporal ultrasound for monitoring tocilizumab treatment in giant cell arteritis: seeing beyond serum markers?
Ann Rheum Dis
November 2021
Rheumatology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece.
Zoledronic acid is effective and safe in migratory osteoporosis.
Rheumatology (Oxford)
February 2020
Rheumatology Department, 417 Army Share Fund Hospital (NIMTS).
Twenty-year scintigraphic follow-up of calcitonin versus zoledronic acid in Paget's disease of bones.
Rheumatology (Oxford)
October 2019
Rheumatology Department, 417 Army Share Fund Hospital (NIMTS).
Rituximab and lenalidomide combination treatment for rheumatoid arthritis complicated with myelodysplastic syndrome: A case report.
Mediterr J Rheumatol
December 2017
Rheumatology Department, 417 Army Share Fund Hospital (NIMTS), Athens, Greece.
Article Synopsis
- Rheumatoid arthritis (RA) patients may face hematologic issues, but the link between RA and myelodysplastic syndrome (MDS) is not well established.
- A limited amount of research exists regarding treatment options for RA patients who also develop MDS.
- This report discusses a case where a patient with RA and worsening MDS was effectively treated using a combination of rituximab and lenalidomide.